Title |
Long‐acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
|
---|---|
Published in |
Cochrane database of systematic reviews, April 2007
|
DOI | 10.1002/14651858.cd005613.pub3 |
Pubmed ID | |
Authors |
Karl Horvath, Klaus Jeitler, Andrea Berghold, Susanne H Ebrahim, Thomas W Gratzer, Johannes Plank, Thomas Kaiser, Thomas R Pieber, Andrea Siebenhofer |
Abstract |
Despite indications from epidemiological trials that higher blood glucose concentrations are associated with a higher risk for developing micro- and macrovascular complications, evidence for a beneficial effect of antihyperglycaemic therapy in patients with type 2 diabetes mellitus is conflicting. Two large studies, the United Kingdom Prospective Diabetes Study (UKPDS) and the University Group Diabetes Program (UGDP), did not find a reduction of cardiovascular endpoints through improvement of metabolic control. The theoretical benefits of newer insulin analogues might result in fewer macrovascular and microvascular events. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 2 | <1% |
Italy | 2 | <1% |
Colombia | 1 | <1% |
Netherlands | 1 | <1% |
Austria | 1 | <1% |
Brazil | 1 | <1% |
South Africa | 1 | <1% |
United Kingdom | 1 | <1% |
Unknown | 293 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 55 | 18% |
Researcher | 37 | 12% |
Student > Bachelor | 35 | 12% |
Student > Ph. D. Student | 34 | 11% |
Student > Postgraduate | 26 | 9% |
Other | 59 | 19% |
Unknown | 57 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 133 | 44% |
Nursing and Health Professions | 19 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 18 | 6% |
Biochemistry, Genetics and Molecular Biology | 11 | 4% |
Agricultural and Biological Sciences | 10 | 3% |
Other | 45 | 15% |
Unknown | 67 | 22% |